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Assessment of Left Atrial Deformation and Function by
2-Dimensional Speckle Tracking Echocardiography in Healthy
Dogs and Dogs With Myxomatous Mitral Valve Disease
M. Baron Toaldo , G. Romito, C. Guglielmini, A. Diana, N.G. Pelle, B. Contiero, and M. Cipone
Background: The assessment of left atrial (LA) function by 2-dimensional speckle tracking echocardiography (STE) holds
important clinical implications in human medicine. Few similar data are available in dogs.
Objectives: To assess LA function by STE in dogs with and without myxomatous mitral valve disease (MMVD), analyz-
ing LA areas, systolic function, and strain.
Animals: One hundred and ﬁfty dogs were divided according to the American College of Veterinary Internal Medicine
classiﬁcation of heart failure: 23 dogs in class A, 52 in class B1, 36 in class B2, and 39 in class C + D.
Methods: Prospective observational study. Conventional morphologic and Doppler variables, LA areas, and STE-based
LA strain analysis were performed in all dogs and results were compared among groups. Correlation analysis was carried out
between LA STE variables and other echocardiographic variables.
Results: Variability study showed good reproducibility for all the tested variables (coeﬃcient of variation <16%). Left
atrial areas, fractional area change, peak atrial longitudinal strain (PALS), peak atrial contraction strain, and contraction
strain index (CSI) diﬀered signiﬁcantly between groups B2 and C + D and all the other groups (overall P < .001), whereas
only PALS diﬀered between groups B1 and A (P = .01). Left atrial areas increased with progression of the disease, whereas
LA functional parameters decreased. Only CSI increased nonsigniﬁcantly from group A to group B1 and then progressively
decreased. Thirty-one signiﬁcant correlations (P < .001, r > .3) were found between conventional left heart echocardiographic
variables and LA areas and strain variables.
Conclusions and Clinical Importance: Left atrial STE analysis provides useful information on atrial function in the dog,
highlighting a progressive decline in atrial function with worsening of MMVD.
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The left atrium (LA) plays an essential role in car-diac performance by means of 3 main functions,
namely reservoir, conduit, and booster pump function.1
Reservoir phase represents the collection of pulmonary
venous ﬂow during ventricular systole, conduit phase is
the passage of blood from the pulmonary veins to the
left ventricle (LV) in early diastole, whereas booster
pump function represents the active contraction in late
diastole. Assessment of LA function is essential for clin-
ical evaluation and prognostic purposes in dogs aﬀected
by myxomatous mitral valve disease (MMVD).2 Several
methods have been used to assess LA function in
humans, including 2-dimensional (2D) and 3-dimen-
sional echocardiography, computed tomography, and
magnetic resonance.3,4 In dogs, the majority of studies
have been focused on conventional echocardiographic
variables, such as calculation of LA phasic sizes (areas
and volumes),5–8 and pulsed-wave Doppler evaluation
of transmitral and pulmonary venous ﬂow.9 Only 1
study evaluated the prognostic relevance of LA function
in dogs with MMVD, showing a worse prognosis in
those animals with a poorer LA systolic function.2
However, most of the studied echocardiographic
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parameters of LA function are highly preload depen-
dent and they are inﬂuenced by changes in hemody-
namic load associated with mitral regurgitation (MR),
thus raising the need for more sophisticated echocardio-
graphic techniques.10 Assessment of atrial deformation
proﬁles obtained by tissue Doppler imaging (TDI) and
its derived variables, strain and strain rate, has been
recently proposed as an alternative method of exploring
LA mechanics in both humans3,4,10 and dogs.11 Never-
theless, a number of potential drawbacks of this
approach should be considered, including suboptimal
reproducibility, angle dependence, and the confounding
eﬀect of noise artifacts.3,4,10,11 Many of these limitations
might be overcome by 2D speckle tracking echocardiog-
raphy (STE), the most recent and promising ultrasound
technology for the direct evaluation of LA function
from standard grayscale echocardiographic images.3,4,10
Speciﬁcally, regional myocardial deformation can be
calculated from continuous frame-by-frame tracking of
the tiny echo-dense speckles created by the interference
between the ultrasound beam and myocardium. The
movement of the speckle during the cardiac cycle fol-
lows myocardial movement, and a change between
speckles is assumed to represent myocardial deforma-
tion. In this manner, STE allows for the assessment of
myocardial function independent of cardiac translation
and angle of insonation.3,4,10 In people, reference range
values, feasibility, and reproducibility of STE for
the study of LA mechanics have been extensively
documented.12–15 Furthermore, the clinical and prognos-
tic importance of STE variables has been demonstrated
in numerous pathophysiologic conditions typically asso-
ciated with abnormal LA function, including MMVD,
atrial ﬁbrillation, systemic hypertension, and dilated, as
well as hypertrophic, cardiomyopathy.3,4,10,16,17 The
majority of STE studies in dogs to date focused on the
evaluation of mechanical ventricular properties.18–27
Few data are available regarding the application of this
technique for LA assessment28–30, and no studies have
focused on the evaluation of LA STE-derived strain in
dogs with cardiac disease.
Therefore, the aims of this study were (1) to docu-
ment the feasibility and reproducibility of STE in the
assessment of LA function in dogs; (2) to compare
selected STE indices of LA function between healthy
dogs and dogs with MMVD at diﬀerent stages; and
(3) to evaluate the association between these indices and
traditional echocardiographic variables.
Materials and Methods
Animals
Dogs were presented to the cardiology unit of the Veterinary
Teaching Hospital of the University of Bologna for cardiac evalu-
ation on the basis of cardiac murmur assessment, clinical signs
referable to heart disease (ie, dyspnea, cough, and syncope), for
breed screening, or for pre-anesthetic assessment. Dogs were
prospectively recruited from January 2011 to December 2014 and
included in the study if they had clinical and echocardiographic
signs typical for MMVD and a body weight (BW) <21 kg. Dogs
with congenital cardiac malformations, dilated cardiomyopathy, or
other acquired cardiac diseases were excluded. Dogs were permit-
ted to receive cardiac medications for congestive heart failure
(CHF) if considered necessary by the clinician. Healthy dogs were
recruited from students, university staﬀ, and owners as the control
group. These animals were considered clinically healthy based on
cardiovascular examination, noninvasive systemic arterial blood
pressure measurements, and complete transthoracic echocardio-
graphic examination.
Procedures
All dogs underwent a complete physical examination, cardiac
auscultation, and noninvasive systemic arterial blood pressure mea-
surement. Complete transthoracic echocardiography (TTE) was per-
formed according to standard techniques31 by 2 investigators (MBT
and MC) using ultrasound unitsa,b equipped with phased array
transducers of various frequencies and continuous ECG tracing.
The diagnosis of MMVD was made based on clinical examination
and echocardiographic criteria including thickening, prolapse, or
both thickening and prolapse of the mitral valve (MV) leaﬂets on
2D echocardiography and MR on color Doppler examination. Wall
thickness and chamber diameter of the LV were obtained from 2D
guided M-mode images acquired from a right parasternal short-axis
view at the level of the papillary muscles. In particular, LV end-dia-
stolic and end-systolic dimensions were normalized to the aortic root
(Ao) diameter and compared with previously published reference
intervals, in order to identify the presence of LV dilatation.32 Left
atrial diameter, Ao diameter, and Ao area were measured on 2D
images obtained from a right parasternal short-axis view at the basi-
lar level,5 and a LA/Ao ratio <1.5 was considered normal.33 Left
ventricular diastolic inﬂow was recorded from the left apical 4-
chamber view placing the sample volume at the level of the MV on
the ventricular side. Three consecutive measurements were averaged
for each variable. Thoracic radiography in 2 orthogonal projections
was performed to exclude or conﬁrm the presence of CHF (pul-
monary edema, pleural eﬀusion, or both) in all dogs with left atrial
dilatation or according to clinical signs of cough, dyspnea, or both.
Radiographic evidence of interstitial opacity in the caudo-dorsal
ﬁelds in the presence of cardiomegaly was considered indicative of
CHF. If CHF was present at the time of presentation, dogs were ﬁrst
stabilized and a complete TTE was then performed for the ﬁrst time
or repeated. Only dogs in sinus rhythm during echocardiography
were included in the study.
According to the guidelines for the diagnosis and treatment of
MMVD,34 dogs were divided into diﬀerent groups as follows: con-
trol, healthy dogs with normal LV and LA dimensions (group A);
dogs having MMVD with normal LV and LA dimensions (group
B1); dogs having MMVD with LV, LA, or both dimensions above
the reference limits32,33 but without conﬁrmed radiographic evi-
dence of CHF (group B2); dogs with symptomatic MMVD and
radiographic evidence of pulmonary edema/pleural eﬀusion; or
dogs with at least 1 conﬁrmed episode of CHF in the past (group
C + D).
Left Atrial Areas and Speckle Tracking
Echocardiography
The same operator (MBT) that was blinded to the dogs’ classiﬁ-
cation performed this part of the analysis. For the analysis of LA
areas and STE, a left apical 4-chamber view was optimized in
order to visualize the LA walls. Then, 3 consecutive cardiac beats
cine loops were acquired and stored in DICOM format for subse-
quent oﬄine analysis. Dedicated softwarec was used to review the
cine loops, the beat with the best image quality was chosen, and
the endocardial border of the LA was automatically drawn by the
software and LA areas provided during the entire cardiac cycle. If
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necessary, manual editing of the tracing was done in order to cor-
rect software errors in tracking the endocardial border. Left atrial
maximal area (LAAmax) and minimal area (LAAmin) expressed
in cm2 were automatically calculated by the software and were
then indexed to Ao area. Left atrial fractional area change (FAC)
was calculated with the formula: FAC = [(LAAmax  LAAmin)/
LAAmax] 9 100, and expressed as a percentage.2
The same cine loops and beats used to measure LA areas were
successively employed for the STE analysis. The operator selected
3 points on the LA (2 on the MV annulus and 1 on the LA roof),
and the software automatically drew a region of interest on the
entire LA wall dividing it into 7 regions (from the basilar segments
to the roof of the LA) (Fig 1). When necessary, the operator man-
ually edited the tracking of each segment, and those segments that
showed artifactual values (due to lung interposition or echo drop-
out at the level of the region of the fossa ovalis or the pulmonary
veins inlet) were excluded from the analysis. The number of seg-
ments considered for each dog was recorded. Time/intensity curves
were then generated for each segment displacing strain values (as
percentages) on the y-axis and time (in seconds) on the x-axis over
an entire cardiac cycle. The software also generated a mean curve
of all the segments that was used by the operator to measure the
peak strain value during LV contraction (peak atrial longitudinal
strain [PALS]), and just before LA active contraction, on the peak
of the P wave of the ECG trace (peak atrial contraction strain
[PACS]). Finally, the contraction strain index (CSI) was calculated
by the formula: CSI = [(PALS/PACS) 9 100] (Fig 1). This last
parameter represents the contribution of LA contraction on LV
ﬁlling.17
Variability Study
To assess measurement variability, 6 dogs enrolled into the
study were randomly selected. For each dog 1 single echocardio-
graphic study was then chosen, thus a total of 6 diﬀerent echocar-
diographic studies were analyzed. For interobserver variability, 2
operators with diﬀerent levels of experience in echocardiography
(MBT, GR) analyzed and measured the LA areas (LAAmax and
LAAmin) and FAC, and LA STE variables (PALS, PACS, CSI).
To assess interday intra-observer variability, the same operator
(MBT) repeated the measurements for each of the 6 dogs on dif-
ferent days (at least 7 days apart). Attention was made to analyze
the same cardiac cycle for each loop. Finally, to assess interday
intra-observer acquisition variability, 5 echocardiographic studies
from the same number of dogs from those enrolled in the control
group, were repeated 1 week apart. Then, the same operator
(MBT) measured LA areas and LA STE variables. The variability
was then quantiﬁed as the coeﬃcient of variation (CV) by use of
the equation CV = (mean diﬀerence between measurement/mean
of measurements)/100 and expressed as a percentage. The degree
of variability was arbitrarily deﬁned as follows: CV <5%, very low
variability; 5–15%, low variability; 16–25%, moderate variability;
or >25%, high variability.35
Statistical Analysis
Descriptive statistics were used for age, sex, and BW. A 1-way
ANOVA and a chi-square test were performed to evaluate the
group eﬀect (A, B1, B2, C + D) on BW and age, and sex,
Fig 1. Representative image of the LA strain proﬁle of a dog. On the top of the panel, the LA visualization is optimized in the left apical
4-chamber view. A region of interest is manually drawn to include the LA wall, which is automatically divided into 7 diﬀerent segments
with diﬀerent colors. On the bottom of the panel, a trace screen of the speckle tracking echocardiography-derived strain (e) is shown, which
is expressed in percentage on the y-axis and time (in seconds) on the x-axis. Diﬀerent colored lines are traced for each LA segment, and
the mean e value over time is presented as a dotted white line. The proﬁle is characterized by 2 positive deﬂections, 1 during ventricular
systole (PALS), and 1 just before LA contraction, on the P wave (PACS, peak contraction strain). The CSI is calculated from PALS and
PACS as their diﬀerence expressed in percentage (see text for details). LA, left atrial; LV, left ventricle; RA, right atrium; RV, right ventri-
cle; PACS, peak atrial contraction strain; PALS, peak atrial longitudinal strain; CSI, contraction strain index.
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respectively. Normal distribution of the echocardiographic, Dop-
pler, and STE-derived variables was assessed by a Shapiro–Wilks
test. Variables not normally distributed were log-transformed. An
ANCOVA model was used to test the ﬁxed eﬀects of the group of
dogs, sex, as well as the continuous variables of heart rate, BW
and age as covariates on echocardiographic, Doppler, and STE-
derived variables. The hypothesis of the linear model was assessed
by visual inspection of the residuals plots.
When a signiﬁcant main eﬀect was detected, a post hoc pairwise
contrast were conducted by a Bonferroni correction. Data were
reported as Least Squares means (LS-means)  Standard error
(SE). The association between STE-derived variables and left heart
measurements was tested with a Pearson correlation index (r) and
considered signiﬁcant for P < .001 and r > .3, then a linear regres-
sion model was applied.36
All statistical analyses were performed by 2 commercial dedi-
cated software programs.d,e An overall value of P < .01 was con-
sidered signiﬁcant.
Results
General Characteristics of the Study Population and
Conventional Echocardiographic Variables
One hundred and ﬁfty dogs met the inclusion criteria.
Of these dogs, 23 (15%) were clinically healthy (group
A), 52 (35%) had MMVD without cardiac enlargement
(group B1), 36 (24%) had MMVD with cardiac enlarge-
ment (group B2), and 39 (26%) had symptomatic
MMVD (group C + D). Dogs in group A were younger
compared with all the other groups, whereas dogs in
group B1 were younger than those in group B2 and
C + D (P < .001). Dogs of group B1 were signiﬁcantly
heavier than those in group C + D (P = .028). Male
dogs were overrepresented in groups B1, B2, and
C + D, whereas female dogs were overrepresented in
group A; however, a statistically relevant diﬀerence was
only observed between groups B2 and A (P = .042).
Mixed-breed dogs were overrepresented (n = 68; 45%),
followed by Cavalier King Charles Spaniels (n = 10;
7%), Yorkshire Terriers (n = 9; 6%), Miniature Poodles
(n = 7; 5%), Maltese (n = 6; 4%), Shih Tzu (n = 6;
4%), and Cocker Spaniels (n = 3; 2%). All descriptive
characteristics of the study population and all drugs
used with potential impact on hemodynamic variables
are summarized in Table 1.
All echocardiographic variables were normally dis-
tributed, except LAAmax/AoArea and LAAmin/
AoArea. The heart rate was higher in dogs of group
C + D compared with those of all other groups
(P < 0.001). There was a progressive increase of MV E
velocity, MV A velocity, and MV E:A ratio when com-
paring dogs of groups A and B1 to those of groups B2
and C + D (P < .001) (Table 2). None of the dogs
had systemic arterial hypertension on noninvasive
measurement.
Table 1. Demographic data from 150 dogs used in this study.
Variable A B1 B2 C + D Overall P
No. of dogs 23 52 36 39
Age (years) 7.0  0.6 9.3  0.4 11.1  0.5* 12.8  0.5*,** <.001
Body weight (kg) 10.5  0.9 11.1  1.0 9.3  1.1 8.1  0.9 .028
Sex (male/female) 8/15 30/22 26/10 21/18 .042
Breed (no. of dogs) Mixed breed (9) Mixed breed (23) Mixed breed (11) Mixed breed (25)
Cocker Spaniel (3) CKCS (8) Yorkshire Terrier (5) Miniature Poodle (5)
Yorkshire Terrier (4) Beagle, Bolognese,
CKCS, Dachshund,
Lagotto Romagnolo,
Shih Tzu (2)
Shih Tzu (4)
Maltese, Miniature
Schnauzer (2)
English Setter,
Jack Russell Terrier,
Maltese, Miniature
Poodle (2)
Maltese (2)
Medications received
(no. of dogs)
[mean dose received]
Other breeds (7)
None
Other breeds (9)
None
Other breeds (8)
None
Other breeds (3)
Benazepril (39)
[0.38 mg/kg q12–24h]
Pimobendan (35)
[0.31 mg/kg q24h]
Amlodipine (5)
[0.3 mg/kg q24h]
Spironolactone (3)
[2 mg/kg q24h]
Furosemide (39)
[2 mg/kg q12h]
A, healthy control group; B1, dogs with MMVD without cardiac enlargement; B2, dogs with MMVD and cardiac enlargement; C + D,
dogs with MMVD and clinical signs due to congestive heart failure; CKCS, Cavalier King Charles Spaniel; MMVD, myxomatous mitral
valve disease.
Data are expressed as Least Squares-Means  SE and numerical data for sex prevalence. In bold values with statistical diﬀerences
*P < .001 compared with group A.
**P < .001 compared with group B1.
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Left Atrial Areas, LA STE Variables, and Correlation
Analysis
For each dog, it was possible to obtain a good
tracking proﬁle of the atria and meaningful values for
LA areas and strain. Similar to the linear measure-
ments, LA areas also increased with progression of
MMVD (Table 2). Speciﬁcally, LAAmax/AoArea and
LAAmin/AoArea were higher in dogs of group B2
compared with those of groups A and B1, whereas
dogs of group C + D had higher values compared with
those of all other groups (P < .001). Fractional area
change was lower in dogs of group B2 compared with
that of group A, whereas dogs of group C + D had
lower values compared with those of all the other
groups (P < .001).
Of 1,050 LA segments (7 for each dog), only 61
segments (5.8%) were censored due to artifacts
whereas the remaining 989 segments (94.2%) were
analyzed. Regarding the strain values, dogs of group
C + D had lower values for PALS compared with
those of all the other groups, and lower PACS values
compared only to groups A and B1; dogs of group
B2 had lower values compared with dogs of groups
B1 and A, whereas dogs of group B1 had lower
PALS values compared with those of group A
(P < .001). The CSI had signiﬁcantly lower values in
dogs of group C + D compared with those of group
B1 and in dogs of group B2 compared with those of
group A (P < .001) (Table 2).
Results of the ANCOVA model did not show a sig-
niﬁcant eﬀect of heart rate or age on each of the tested
variables. Body weight had a signiﬁcant negative eﬀect
on FAC, PALS and PACS, a positive eﬀect on LAA-
max/AoArea and LAAmin/AoArea, and no eﬀect on
CSI.
The correlation analysis demonstrated several positive
and negative correlations between the LA STE-derived
variables and morphologic and Doppler variables of the
LA and LV. In particular, 31 signiﬁcant correlations
(P < .001) with values of r > .3 were found between LA
areas and functional variables (FAC, PALS, PACS, and
CSI) and conventional left heart echocardiographic
variables (Table 3; Fig 2).
Variability Study
The interobserver measurement variability was low
for the 6 tested STE variables, with CV values always
below 16%. Intra-observer interday measurement vari-
ability was always very low or low, with CV values
always below 13% for PALS, PACS and CSI and
below 7% for LAAmax, LAAmin and FAC. Interday
intra-observer acquisition variability was low (between
5% and 15%) for all variables expect FAC, where the
variability was 16%.
Table 2. Conventional echocardiographic and left atrial STE-derived variables from a population of 23 healthy
dogs (A) and 127 dogs with MMVD at diﬀerent stages.
Variable A (n = 23) B1 (n = 52) B2 (n = 36) C + D (n = 39)
Overall
P Value
Conventional
Heart rate (bpm) 137  6 130  4 135  4.8 160  4.6*,§§§,## <.001
MV E vel (cm/s) 71.3  5.64 77.2  3.71 112.7  4.45***,§§§ 139.1  4.31***,§§§,### <.001
MV A vel (cm/s) 63.2  5.24 71.7  3.49 83.7  4.19* 97.2  4.03***,§§§ <.001
MV E/A 1.2  0.09 1.1  0.06 1.4  0.07§ 1.6  0.07**,§§§ <.001
STE
LAAmax/AoArea 2.2 (1.9–2.4) 2.7 (2.4–3.0) 3.6 (3.3–4.1) ***,§§ 5.2 (4.7–5.9) ***,§§§,## <.001
LAAmin/AoArea 0.9 (0.8–1.1) 1.3 (1.2–1.5) 2.0 (1.8–2.3) ***,§§ 3.5 (3.0–4.0) ***,§§§, ### <.001
FAC (%) 55.1  2.09 49.2  1.39 44.7  1.67*** 36.2  1.60***,§§§,## <.001
PALS (%) 60.4  2.36 49.8  1.57** 40.6  1.89***,§§ 28.9  1.81***,§§§,### <.001
PACS (%) 26.3  1.77 24.3  1.18 16.5  1.42***,§§§ 10.6  1.32***,§§§,# <.001
CSI (%) 42.8  3.24 49  2.16 40.0  2.59** 33.9  2.49§§§ <.001
C + D, dogs with MMVD and clinical signs due to congestive heart failure; MV E vel, mitral valve E wave peak velocity; MV A vel,
mitral valve A wave peak velocity; E/A, mitral valve peak E; and A wave velocity ratio; LAAmax/AoArea, left atrial maximal area-to-aor-
tic area ratio; LAAmin/AoArea, left atrial minimal area-to-aortic area ratio; FAC, left atrial fractional area change; PALS, peak atrial lon-
gitudinal strain; PACS, peak atrial contraction strain; CSI, contraction strain index; MMVD, myxomatous mitral valve disease; STE,
speckle tracking echocardiography.
Data are expressed as LSmeans  SE. LAAmax/AoArea and LAAmin/AoArea mean values are reported after anti-log transformation
and CI are reported into parentheses. In bold values with statistical diﬀerences.
*P < .05 compared with group A (healthy dogs).
**P < .01 compared with group A.
***P ≤ .001 compared with group A.
§P < .05 compared with group B1 (dogs with MMVD without heart enlargement).
§§P < .01 compared with group B1.
§§§P < .001 compared with group B1.
#P < .05 compared with group B2 (dogs with MMVD and heart enlargement).
##P < .01 compared with group B2.
###P ≤ .001 compared with group B2.
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Discussion
In the present study we evaluated novel echocardio-
graphic indices of LA function in healthy dogs and
dogs with MMVD. The major ﬁndings were: (1) LA
STE analysis is feasible and reproducible in the dog, (2)
several statistical signiﬁcant diﬀerences exist in LA STE
variables between healthy dogs and dogs with MMVD
at diﬀerent stages of severity, indicating a progressive
impairment of LA function with the disease progres-
sion, and (3) a strong association is present between LA
STE-derived indices and some conventional echocardio-
graphic variables, supporting a reduction of LA func-
tion as the heart dilates.
Two-dimensional STE was feasible and repeatable for
evaluation of LA longitudinal strain in awake, unse-
dated dogs with and without MMVD, with a lower
variability compared with TDI-derived LA strain imag-
ing in healthy dogs.11 Speciﬁcally, intra- and interob-
server variability was considered clinically acceptable
(CV <16%) for all STE measurements. In addition, the
obtained images were of suﬃcient quality to allow STE
analysis, both in dogs with a structurally normal LA
and in dogs with an enlarged LA. Similar data have
been reported in healthy people, where adequate track-
ing quality was achieved in >95% of segments analyzed
and inter- and intra-observer variability coeﬃcients of
measurements ranged approximately between 3% and
6%.13,37 The CV relative to LAAmax, LAAmin and
FAC were slightly lower than those obtained for the
STE variables (PALS, PACS, and CSI). This ﬁnding
could be explained by the fact that the more complex
software analysis needed to calculate the STE variables
and the need of analyzing high-quality images, might
increase their variability, whereas the simple area mea-
surements, which require less computation and not nec-
essarily high-quality images, allow higher repeatability.
Speckle tracking echocardiography analysis allows an
excellent assessment of the LA deformation proﬁle dur-
ing an entire cardiac cycle, closely following LA
physiology. In particular, during the period of LV sys-
tole, the LA acts as a reservoir allowing collection of
blood from the pulmonary veins whereas the MV is
closed. Consequently, longitudinal elongation of the LA
walls occurs, resulting in a LA strain increase character-
ized by a peak at the end of LA ﬁlling, just before MV
opening. During the successive conduit phase, the MV
opens and the LA empties quickly; the shortening of
LA walls results in a strain decrease, up to a plateau
corresponding to the phase of diastole. Finally, after
the P wave of the ECG, the LA acts as an active con-
tractile chamber in order to complete the LV ﬁlling,
reaching a second negative peak at the end of LA
contraction.11,13,16 Starting from the above-described
strain curve, speciﬁc STE variables of LA function can
be calculated, including PALS and PACS, which reﬂect
the LA function during its reservoir and booster pump
phase, respectively.17 In addition, CSI can be also
obtained from these 2 variables, representing the contri-
bution of LA active contraction to the LV ﬁlling
phase.17 Our results showed a linear decrease of LA
STE-derived measurements including FAC, another
index of LA function, from healthy dogs to dogs with
progressively more severe MMVD. In addition, a nega-
tive correlation was found between the above-men-
tioned STE-derived variables and conventional
echocardiographic measurements of left cardiac cham-
ber size. These data are in agreement with previous
reports focused on conventional echocardiographic
assessment of LA function in dogs with MMVD,2,7 as
well as human studies in patients investigated by
STE,38–44 and suggest progressive LA dysfunction with
worsening of MMVD and LA dilatation. These ﬁndings
might be explained by the progressive LA volume over-
load due to MR and remodeling and by an increase in
LV ﬁlling pressures in the advanced phases of the dis-
ease. Speciﬁcally, LA remodeling includes adaptive and
maladaptive processes, such as alterations in the com-
position of extracellular matrix with excessive ﬁbroblast
proliferation, and myocyte hypertrophy, necrosis, and
Table 3. Correlation analysis between speckle tracking echocardiography-derived variables and some selected con-
ventional echocardiographic parameters in the 150 dogs used in this study.
Variable
LAAmax/
AoArea
LAAmin/
AoArea FAC PALS PACS CSI
r P r P r P r P r P r P
Heart rate (bpm) .268 <.001 .300 <.001 .129 .116 .183 .025 .113 .170 .025 .757
LA/Ao .750 <.001 .756 <.001 .538 <.001 .609 <.001 .539 <.001 .303 .002
LVIDd/Ao .697 <.001 .693 <.001 .473 <.001 .540 <.001 .521 <.001 .332 <.001
LVIDs/Ao .452 <.001 .458 <.001 .356 <.001 .315 <.001 .309 .001 .187 .022
MV E vel (cm/s) .644 <.001 .669 <.001 .515 <.001 .593 <.001 .586 <.001 .385 <.001
MV A vel (cm/s) .405 <.001 .384 <.001 .200 .014 .279 .001 .206 .012 .028 .731
E/A .312 <.001 .362 <.001 .400 <.001 .398 <.001 .460 <.001 .385 <.001
LAAmax/AoArea, left atrial maximal area-to-aortic area ratio; LAAmin/AoArea, left atrial minimal area-to-aortic area ratio; FAC, left
atrial fractional area change; PALS, peak atrial longitudinal strain; PACS, peak atrial contraction strain; CSI, contraction strain index;
LA/Ao, left atrium-to-aorta ratio; LVIDd/Ao, left ventricular internal diameter in diastole-to-aorta ratio; LVIDs/Ao, left ventricular inter-
nal diameter in systole-to-aorta ratio; MV E vel, mitral valve E wave peak velocity; MV A vel, mitral valve A wave peak velocity; E/A,
mitral valve peak E and A wave velocity ratio.
In bold values with signiﬁcant correlation (P < .001, r > .3).
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apoptosis.45,46 All of these ultrastructural changes sig-
niﬁcantly aﬀect LA myocardial wall properties, such as
relaxation and compliance, ultimately leading to the
observed reduction of LA phasic functions assessed by
STE.40,47,48 An interesting ﬁnding of the present study
was the observed lower PALS in dogs with MMVD
class B1 compared with that of healthy dogs, whereas
LA areas and almost all STE-derived variables were not
diﬀerent between these groups of dogs. This ﬁnding
suggests a possible early eﬀect of MR on LA structure
and function that was only evident by strain analysis in
this study. Although canine MMVD progresses in the
absence of signiﬁcant ventricular myocardial ﬁbrosis,49
PALS has been proven to highly correlate with LA
ﬁbrosis in human patients with MR.38 At present, stud-
ies investigating the role of LA ﬁbrosis in dogs in the
early stage of MMVD are lacking. On the other hand,
because dogs of group A were signiﬁcantly younger
than those of the other groups, it cannot be excluded
that an age-related eﬀect might also have inﬂuenced this
ﬁnding. Contraction strain index, a parameter indicative
of LA active systolic function, showed a transient
increase from dogs of group A to those of group B1
followed by a progressive reduction. This supernormal
pattern has already been observed in humans with mild
MR, and it is likely secondary to Starling’s law usually
applied to the ventricles.37 In fact, the atria also
enhance their contractile function in response to an
increased preload during the early phase of MR, but
this function subsequently declines as the LV ﬁlling
pressure increases.37
In the present study, we recorded relatively higher
values of PALS, PACS, and CSI in our control group
compared with those recently reported in healthy
dogs.30 This diﬀerence might be explained by the diﬀer-
ent equipment and software used for the analysis in the
2 studies, and also by the diﬀerent demographic popula-
tions. The dogs enrolled in that previous study had a
relatively broad range of breeds, age, and BW, whereas
dogs of the present study were comparably older and
smaller in size. Although no association was found
between STE variables and BW and age in the reported
study,30 we cannot exclude a possible BW and age eﬀect
on STE variables.
Some limitations of the present study must be high-
lighted. First, technical aspects of STE-derived variables
should be considered, because the reliability of measure-
ments might be questioned in dogs with extremely
remodeled LA. In these cases, excessive dilatation of
the pulmonary vein inlet and displacement of the intera-
trial septum might complicate the tracking procedure.
These structures were excluded from tracking analysis,
therefore reducing the risk of producing artifactual data
among the global LA strain. Moreover, we documented
a low intra- and interobserver variability in all groups
of dogs, including those of group C + D, where the
described anatomical modiﬁcations are common. Sec-
ond, dogs aﬀected by MMVD were older than those of
the control group. However, given the acquired and
progressive nature of MMVD, it is diﬃcult to ﬁnd a
perfectly age- and BW-matched control group of dogs
without some degree of MR, and age did not have any
signiﬁcant eﬀect on STE-derived variables in the
ANCOVA model. Third, a possible inﬂuence of cardiac
medications on LA function could not be evaluated in
Fig 2. Linear regression analysis of 4 selected LA strain variables
and FAC obtained from LA areas, compared with LA linear
dimension normalized to aortic root diameter (LA/Ao). LA, left
atrial diameter; AO, aortic diameter; PALS, peak atrial longitudi-
nal strain; PACS, peak atrial contraction strain; CSI, contraction
strain index; FAC, fraction area change.
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the present study. However, only 39 of 127 (31%) dogs
with MMVD received cardiac medications at the time
of enrollment, and diﬀerent drug combinations and
dosages were employed. Finally, LA mechanical proper-
ties were not assessed for functional impairment by gold
standard imaging modalities, such as cardiac computed
tomography and magnetic resonance. However, given
the need of general anesthesia and the related risks
(especially in dogs with decompensated MMVD), these
procedures were not carried out for ethical reasons.
In conclusion, we described the use of STE for the
evaluation of LA strain and other functional indexes
in healthy dogs and dogs with MMVD. These vari-
ables can be eﬀectively obtained also in dogs in the
advanced stages of MMVD and are useful to track
the progressive decline in LA function as the disease
progresses.
Footnotes
a iU22 ultrasound system, Philips Healthcare, Monza, Italy
b iE33 ultrasound system, Philips Healthcare, Monza, Italy
c QLAB quantiﬁcation software version 9.1, Philips Healthcare,
Monza, Italy
d SAS version 9.3, SAS Institute Inc., Cary, NC
e MedCalc version 12.6.1.0, MedCalc Software, Ostend, Belgium
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